Dana G. Mead

Between 2008 and 2012 he made
$465,760
as a director, more than 25% of all directors

Paid CEOs an average of
$24,688,849
in the last year of his directorship, more than 79% of all directors

Increased CEO pay by an average of
$9,141,249
between 2008 and 2012, more than 87% of all directors

Shares of his companies decreased by
27.6%
between 2008 and 2012, better performance than 41% of all directors

The Dana G. Mead Stock Index

From January 2008 to April 2010, if you bought shares in companies when Dana G. Mead joined the board, and sold them when he left, you would have a -27.6 percent return on your investment, compared to a -17.7 percent return from the S&P 500.

Dana G. Mead's companies

Pfizer

Jan. 1, 1998 to April 22, 2010

Other board members at Pfizer during this time were Constance J. Horner, Dennis A. Ausiello, Dr. Michael S. Brown and 12 more.

His Yearly Compensation

Yearly Payments to CEOs

MEDIAN

Stock Performance is the difference between a director's stock index and the S&P 500.
A director's stock index is an unweighted index of company stock performances while they sat on the board.
CEO pay includes salary, bonuses, stock sales, and other payments.
Average CEO Pay is calculated using the last year a director sat on the board of each company.
Stock returns do not include dividends.
All directors refers to people who sat on the board of at least one Fortune 100 company between 2008 and 2012.

The Pay Pals project relies on financial research conducted by the Center for Economic Policy and Research.

Sources: Google Finance, Yahoo Finance, Pfizer SEC filings (2008, 2009, 2010).

By Shane Shifflett, Jay Boice, Hilary Fung and Aaron Bycoffe